{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T04:44:06Z","timestamp":1751085846032,"version":"3.35.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-025-08754-5","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T14:37:56Z","timestamp":1738593476000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Enhancing vaccine clinical trials participation among elderly: challenges and strategies"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2841-0170","authenticated-orcid":false,"given":"Paul","family":"Gillard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samer","family":"Nakhle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darin","family":"Brimhall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ouzama","family":"Henry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narcisa","family":"Mesaros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"key":"8754_CR1","unstructured":"United Nations Department of Economic and Social Affairs, Population Division (2022). World Population  Prospects 2022: Summary of Results. UN DESA\/POP\/2022\/TR\/NO. 3"},{"key":"8754_CR2","unstructured":"TrialTrove (2023) Query on [(Min Patient Age is 65) AND (Patient Age Group is Older Adults) AND (Therapeutic Class is Prophylactic vaccine, anti-infective)]. Retrieved from TrialTrove database, accessed on Feb-2023."},{"key":"8754_CR3","doi-asserted-by":"publisher","first-page":"249","DOI":"10.15441\/ceem.17.261","volume":"5","author":"SB Lee","year":"2018","unstructured":"Lee SB, Jae Hun Oh, Park JH, Choi SP, Wee JH. Differences in youngest-old, middle-old, and oldest-old patients who visit the emergency department. Clinical and Experimental Emergency Medicine. 2018;5:249\u201355.","journal-title":"Clinical and Experimental Emergency Medicine"},{"key":"8754_CR4","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","volume":"372","author":"Lal, H., A. L. Cunningham, O. Godeaux, R. Chlibek, J. Diez-Domingo, S. J. Hwang, M. J. Levin, J. E. McElhaney, A. Poder, J. Puig-Barbera, T. Vesikari, D. Watanabe, L. Weckx, T. Zahaf, T. C. Heineman, and Z. O. E. Study Group","year":"2015","unstructured":"Lal, H., A. L. Cunningham, O. Godeaux, R. Chlibek, J. Diez-Domingo, S. J. Hwang, M. J. Levin, J. E. McElhaney, A. Poder, J. Puig-Barbera, T. Vesikari, D. Watanabe, L. Weckx, T. Zahaf, T. C. Heineman, and Z. O. E. Study Group. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults (ZOE-006). N Engl J Med. 2015;372:2087\u201396.","journal-title":"N Engl J Med"},{"key":"8754_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/epirev\/mxs009","volume":"35","author":"ME Salive","year":"2013","unstructured":"Salive ME. Multimorbidity in older adults. Epidemiol Rev. 2013;35:75\u201383.","journal-title":"Epidemiol Rev"},{"key":"8754_CR6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13195-016-0201-2","volume":"8","author":"R Banzi","year":"2016","unstructured":"Banzi R, Camaioni P, Tettamanti M, Bertele V, Lucca U. Older patients are still under-represented in clinical trials of Alzheimer\u2019s disease. Alzheimers Res Ther. 2016;8:32.","journal-title":"Alzheimers Res Ther"},{"key":"8754_CR7","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s40264-015-0330-8","volume":"38","author":"P Pellegrino","year":"2015","unstructured":"Pellegrino P, Perrotta C, Clementi E, Radice S. Vaccine-Drug interactions: cytokines, cytochromes, and molecular mechanisms. Drug Saf. 2015;38:781\u20137.","journal-title":"Drug Saf"},{"key":"8754_CR8","doi-asserted-by":"crossref","unstructured":"Yoshikawa TT. Epidemiology and unique aspects of aging and infectious diseases. Clin Infect Dis. 2000;30(6):931\u20133.","DOI":"10.1086\/313792"},{"key":"8754_CR9","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41579-020-00506-3","volume":"19","author":"F Micoli","year":"2021","unstructured":"Micoli F, Bagnoli F, Rappuoli R, Serruto D. The role of vaccines in combatting antimicrobial resistance. Nat Rev Microbiol. 2021;19:287\u2013302.","journal-title":"Nat Rev Microbiol"},{"key":"8754_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.idnow.2022.12.005","volume":"53","author":"A Biguenet","year":"2023","unstructured":"Biguenet A, Bouxom H, Bertrand X, Slekovec C. Antibiotic resistance in elderly patients: comparison of Enterobacterales causing urinary tract infections between community, nursing homes and hospital settings. Infect Dis Now. 2023;53: 104640.","journal-title":"Infect Dis Now"},{"key":"8754_CR11","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","volume":"381","author":"A Clegg","year":"2013","unstructured":"Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381:752\u201362.","journal-title":"Lancet"},{"key":"8754_CR12","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s10522-010-9292-5","volume":"11","author":"RE Hubbard","year":"2010","unstructured":"Hubbard RE, Woodhouse KW. Frailty, inflammation and the elderly. Biogerontology. 2010;11:635\u201341.","journal-title":"Biogerontology"},{"key":"8754_CR13","doi-asserted-by":"publisher","first-page":"e166","DOI":"10.1016\/S2666-7568(22)00012-5","volume":"3","author":"DC Vinh","year":"2022","unstructured":"Vinh DC, Gouin JP, Cruz-Santiago D, Canac-Marquis M, Bernier S, Bobeuf F, Sengupta A, Brassard JP, Guerra A, Dziarmaga R, Perez A, Sun Y, Li Y, Roussel L, Langelier MJ, Ke D, Arnold C, Whelan M, Pelchat M, Langlois MA, Zhang X, Mazer BD, Force C-I, U. NCoVER Investigators. Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study. Lancet Healthy Longev. 2022;3:e166\u201375.","journal-title":"Lancet Healthy Longev"},{"key":"8754_CR14","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1016\/j.vaccine.2015.07.003","volume":"33","author":"CA DiazGranados","year":"2015","unstructured":"DiazGranados CA, Dunning AJ, Robertson CA, Talbot HK, Landolfi V, Greenberg DP. Efficacy and immunogenicity of high-dose influenza vaccine in older adults by age, comorbidities, and frailty. Vaccine. 2015;33:4565\u201371.","journal-title":"Vaccine"},{"key":"8754_CR15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41541-022-00548-z","volume":"7","author":"SP Sadarangani","year":"2022","unstructured":"Sadarangani SP, Young BE, Lian W, Phua HP, Chen MI, Barr I, Yeo TW, Dalan R, Chow A. DYNAMIC cohort study evaluating metabolic predictors of influenza vaccine immune response in older adults. NPJ Vaccines. 2022;7:135.","journal-title":"NPJ Vaccines"},{"key":"8754_CR16","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1093\/gerona\/glac095","volume":"77","author":"CT Semelka","year":"2022","unstructured":"Semelka CT, DeWitt ME, Callahan KE, Herrington DM, Alexander-Miller MA, Yukich JO, Munawar I, McCurdy LH, Gibbs MA, Weintraub WS, Sanders JW. Frailty and COVID-19 mRNA vaccine antibody response in the COVID-19 community research partnership. J Gerontol A Biol Sci Med Sci. 2022;77:1366\u201370.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"8754_CR17","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1007\/s12603-023-1994-x","volume":"27","author":"TY Lin","year":"2023","unstructured":"Lin TY, Hung SC. Frailty and humoral immune responses following COVID-19 vaccination among patients undergoing hemodialysis. J Nutr Health Aging. 2023;27:980\u20136.","journal-title":"J Nutr Health Aging"},{"key":"8754_CR18","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s12877-020-01801-7","volume":"20","author":"S Church","year":"2020","unstructured":"Church S, Rogers E, Rockwood K, Theou O. A scoping review of the Clinical Frailty Scale. BMC Geriatr. 2020;20:393.","journal-title":"BMC Geriatr"},{"key":"8754_CR19","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1365-2567.2007.02555.x","volume":"120","author":"D Aw","year":"2007","unstructured":"Aw D, Silva AB, Palmer DB. Immunosenescence: emerging challenges for an ageing population. Immunology. 2007;120:435\u201346.","journal-title":"Immunology"},{"key":"8754_CR20","unstructured":"Research involving individuals with questionable capacity to consent: points to consider https:\/\/grants.nih.gov\/grants\/policy\/questionablecapacity.htm"},{"key":"8754_CR21","first-page":"353","volume":"23","author":"K Christensen","year":"1995","unstructured":"Christensen K, Haroun A, Schneiderman LJ, Jeste DV. Decision-making capacity for informed consent in the older population. Bull Am Acad Psychiatry Law. 1995;23:353\u201365.","journal-title":"Bull Am Acad Psychiatry Law"},{"key":"8754_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/07317115.2016.1201714","volume":"40","author":"B Prusaczyk","year":"2017","unstructured":"Prusaczyk B, Cherney SM, Carpenter CR, DuBois JM. Informed consent to research with cognitively impaired adults: transdisciplinary challenges and opportunities. Clin Gerontol. 2017;40:63\u201373.","journal-title":"Clin Gerontol"},{"key":"8754_CR23","doi-asserted-by":"publisher","first-page":"afad082","DOI":"10.1093\/ageing\/afad082","volume":"52","author":"VA Goodwin","year":"2023","unstructured":"Goodwin VA, Low MSA, Quinn TJ, Cockcroft EJ, Shepherd V, Evans PH, Henderson EJ, Mahmood F, Ni Lochlainn M, Needham C, Underwood BR, Arora BR, Witham MD. Including older people in health and social care research: best practice recommendations based on the INCLUDE framework. Age Ageing. 2023;52:afad082.","journal-title":"Age Ageing"},{"key":"8754_CR24","doi-asserted-by":"publisher","unstructured":"Nelson Kakulla. Brittne. 2020 tech trends of the 50+. Washington, DC: AARP Research, January 2020. https:\/\/doi.org\/10.26419\/res.00329.001","DOI":"10.26419\/res.00329.001"},{"key":"8754_CR25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s44247-024-00100-0","volume":"2","author":"PC Hegeman","year":"2024","unstructured":"Hegeman PC, Vader DT, Kamke K, El-Toukhy S. Patterns of digital health access and use among US adults: a latent class analysis. BMC Digit Health. 2024;2:42.","journal-title":"BMC Digit Health."},{"key":"8754_CR26","doi-asserted-by":"publisher","DOI":"10.2196\/49476","volume":"25","author":"D Riedl","year":"2023","unstructured":"Riedl D, Lehmann J, Rothmund M, Dejaco D, Grote V, Fischer MJ, Rumpold G, Holzner B, Licht T. Usability of electronic patient-reported outcome measures for older patients with cancer: secondary analysis of data from an observational single center study. J Med Internet Res. 2023;25: e49476.","journal-title":"J Med Internet Res"},{"key":"8754_CR27","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1097\/JIM.0000000000000097","volume":"62","author":"JK Holzer","year":"2014","unstructured":"Holzer JK, Ellis L, Merritt MW. Why we need community engagement in medical research. J Investig Med. 2014;62:851\u20135.","journal-title":"J Investig Med."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-08754-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-08754-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-08754-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T14:38:02Z","timestamp":1738593482000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-025-08754-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8754"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-08754-5","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,3]]},"assertion":[{"value":"28 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"PG, NM, and DB are employees of PPD part of Thermo Fisher Scientific. OH is an employee of Dynavax. SN is the medical director of Palm Medical Group.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}